Oxalic Acid

Oxalic Acid

SCHEMBL72933

O.O.O.O.O.O.O=C([O-])C(=O)[O-].O=C([O-])C(=O)[O-].O=C([O-])C(=O)[O-].[Fe+3].[Fe+3]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.70
FAHD1 Q6P587 1/20 0.70
MEN1 O00255 1/20 0.43
LDHA P00338 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
CA1 P00915 2/20 0.42
LMNA P02545 2/20 0.33
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL3136563 1.00 CA4 (0.70) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL5163212 1.00 CA4 (0.70) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL284712 1.00 CA4 (0.70) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL222275 1.00 CA4 (0.70) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL17203391 0.95 CA4 (0.64) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL5398095 0.95 CA4 (0.64) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL3811055 0.95 CA4 (0.64) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL1331098 0.95 CA4 (0.64) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL5525432 0.94 CA4 (0.78) CA4FAHD1MEN1LDHABLM
Oxalic Acid SCHEMBL693885 0.94 CA4 (0.78) CA4FAHD1MEN1LDHABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120082281-A Preparation method of two-dimensional porous double transition metal oxide composite self-repairing noise-reducing anticorrosive coating 中国海洋大学 2025-06-03 CN claimed
CN-108892604-B Method for preparing halogenated benzo [ b ] fluorenone series compounds 江西师范大学 2022-05-31 CN claimed
US-11260369-B2 Catalytic composition, method of making and catalytic application thereof for producing ester(s) of glycerol BHARAT PETROLEUM CORPORATION LIMITED (IN) 2022-03-01 US claimed
CN-113563231-A Para C-H alkylated arylamine and preparation method thereof 黑龙江大学 2021-10-29 CN claimed
US-20210131201-A1 OIL SWELLABLE MATERIAL FOR LOW TEMPERATURE LOST CIRCULATION MATERIAL APPLICATION HALLIBURTON ENERGY SERVICES, INC. (US) 2021-05-06 US claimed
WO-2021086416-A1 OIL SWELLABLE MATERIAL FOR LOW TEMPERATURE LOST CIRCULATION MATERIAL APPLICATION HALLIBURTON ENERGY SERVICES, INC. (US) 2021-05-06 WO claimed
CN-110003061-B Method for direct amination of methyl aromatic compound benzyl hydrocarbon under catalysis of iron 河南农业大学 2021-04-02 CN claimed
EP-3274298-B1 METHOD FOR PREPARING A CATALYST AND METHOD FOR GREEN BIODIESEL PRODUCTION FROM UNREFINED LOW GRADE FEEDSTOCK UNIV HONG KONG POLYTECHNIC (CN) 2019-10-09 EP claimed
US-10100132-B2 Process for the preparation of polymers containing amino groups employing a heterogeneous iron catalyst ARLANXEO DEUTSCHLAND GMBH (US) 2018-10-16 US claimed
US-9694350-B2 Methods and catalysts for green biodiesel production from unrefined low grade feedstock THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2017-07-04 US claimed
US-20170081430-A1 PROCESS FOR THE PREPARATION OF POLYMERS CONTAINING AMINO GROUPS EMPLOYING A HETEROGENEOUS IRON CATALYST ARLANXEO DEUTSCHLAND GMBH (DE) 2017-03-23 US claimed
US-20160279616-A1 METHODS AND CATALYSTS FOR GREEN BIODIESEL PRODUCTION FROM UNREFINED LOW GRADE FEEDSTOCK THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2016-09-29 US claimed
US-20120318510-A1 METHODS OF GENERATING MAGNETIC PARTICLES IN A SUBTERRANEAN ENVIRONMENT SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2012-12-20 US claimed
US-7892520-B2 grinding hydrated iron salts, inorganic salts and alkali hydroxides, then heat treating the mixture to form hematite nanostructure particles, used as magnetic resonance image contrast agents, inks, artificial tanning pigments, photocatalysts, red pigments, water treatment adsorbents or catalyst supports THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2011-02-22 US claimed
US-20080181843-A1 Solid-state synthesis of iron oxide nanoparticles THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2008-07-31 US claimed
EP-4649086-A1 PROTEASE INHIBITORS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION Merck Sharp & Dohme LLC (US) 2025-11-19 EP disclosed
US-12377100-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2025-08-05 US disclosed
US-20080181843-A1 Solid-state synthesis of iron oxide nanoparticles THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2008-07-31 US disclosed
EP-1704057-A1 LASER IMAGING Sherwood Technology LTD. (GB) 2006-09-27 EP disclosed
WO-2005068207-A1 LASER IMAGING DATALASE LTD. (GB) 2005-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12377100-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 CA4 4813/4885FAHD1 3601/4885MEN1 4835/4885
US-11260369-B2 Catalytic composition, method of making and catalytic application thereof for producing ester(s) of glycerol MGLL, AGL, GK CA4 389/4885FAHD1 1189/4885MEN1 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.